Key facts
| Price (PPV) | 89.90 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | méthotrexate |
| Class | Antineoplastic agents |
| ATC code | L01BA01 |
| Manufacturer | IBERMA |
| Presentation | Boite unitaire |
| Hospital price | 56.20 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement de la polyarthrite rhumatoïde active de l'adulte, des formes polyarticulaires actives et sévères de l'arthrite juvénile idiopathique, du psoriasis vulgaris sévère et invalidant et du rhumatisme psoriasique sévère chez l'adulte.
Find an open pharmacy
On-call pharmacies near you
About Quinux 7.5 mg / 0.3 ml
Quinux 7.5 mg / 0.3 ml belongs to the antineoplastic agents therapeutic class. In Morocco, this drug is marketed by IBERMA and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Quinux 7.5 mg / 0.3 ml, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Quinux 7.5 mg / 0.3 ml
Answers to common questions from Moroccan patients about this drug.